Abstract
We report a 1-year-old female child presenting with hypereosinophilia who was found to have concurrent myeloid sarcoma and a central nervous system (CNS) atypical teratoid/rhabdoid tumor (AT/RT). She was later found to have a germline mutation in SMARCB1. Concurrent hematologic malignancy and CNS AT/RT have not previously been described in the context of a SMARCB1 loss-of-function germline mutation.
Keywords:
SMARCB1; brain tumors; eosinophilia; myeloid sarcoma.
© 2017 Wiley Periodicals, Inc.
MeSH terms
-
Eosinophilia / etiology*
-
Female
-
Germ-Line Mutation*
-
Humans
-
Infant
-
Neoplasms, Multiple Primary / complications
-
Neoplasms, Multiple Primary / genetics*
-
Neoplasms, Multiple Primary / pathology
-
Rhabdoid Tumor / complications
-
Rhabdoid Tumor / genetics*
-
Rhabdoid Tumor / pathology
-
SMARCB1 Protein / genetics*
-
Sarcoma, Myeloid / complications
-
Sarcoma, Myeloid / genetics*
-
Sarcoma, Myeloid / pathology
-
Teratoma / complications
-
Teratoma / genetics*
-
Teratoma / pathology
Substances
-
SMARCB1 Protein
-
SMARCB1 protein, human